More women under 40 choosing double mastectomy to prevent recurrence of cancer

Oct 08, 2009 By Josephine Marcotty

Women with breast cancer who are under the age of 40 and who have women surgeons are more likely to opt to have their healthy breasts removed to prevent recurrence, a University of Minnesota study has found.

Researchers have known for some time that a small but growing number of women with breast cancer are choosing a double mastectomy, even when they have other less radical options.

A study published earlier this year by Dr. Todd Tuttle at the university found that while the vast majority of women with the early cancer, known as in situ (DCIS), choose to have only the cancerous tissue removed, a growing number are opting for double mastectomies. Between 1998 and 2005 the number who chose the more aggressive option rose from 2.1 percent to 5.2 percent, a 148 percent increase, he found.

While a double mastectomy greatly reduces the risk of cancer occurring in the other, healthy breast, it does not improve breast cancer survival rates, research has shown.

In this new study, Tuttle looked at the records of 571 Minnesota breast cancer patients at six of the Fairview Health Services Hospitals, including the University Medical Center. The group included women between 18 and 80 years who had breast cancer surgery for invasive breast cancer or DCIS in 2006 and 2007.

About half had surgery to conserve the cancerous breast, a third had a mastectomy to remove the breast. A total of 92 had a double mastectomy, he found.

Those who chose the double mastectomy were more likely to be young, and have larger tumors. Though there were only three surgeons out of 23 who were women, their rates of doing double mastectomy surgeries were 46 percent compared with 23 percent for male surgeons.

Tuttle said in the study that since there were so few surgeons in the study, the findings were not conclusive. It could be, he said, that patients who want aggressive treatment may be more likely to choose female surgeons.

"Several other research studies have established that the surgeon is a critical factor contributing to the decision of surgical treatment for breast cancer," he said. "However, it was not clear in our study whether female surgeons recommend (double mastectomy) more often than their male counterparts, or if patients diagnosed with may be more receptive and comfortable talking about (it) with a female surgeon," he said.
___

(c) 2009, Star Tribune (Minneapolis)
Visit the Star Tribune Web edition on the World Wide Web at www.startribune.com
Distributed by McClatchy-Tribune Information Services.

Explore further: Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Related Stories

Second lumpectomy for breast cancer reduces survival rates

Oct 02, 2008

A majority of women with breast cancer today are candidates for lumpectomy, allowing for conservation of most of their breast tissue. Results of a UC Davis study, however, show that a number of women whose cancer recurs in ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.